Rob Shieff talks about the removal of alprazolam (Xanax) from the New Zealand pharmaceutical schedule and issues around benzodiazepine prescribing. Rob is a general adult psychiatrist practising in Auckland. His special interest is in the evaluation and management of anxiety and mood disorders. Rob has considerable experience in psycho-pharmacology and in delivering evidence based forms of psychotherapy.